| ACE2 | Angiotensin-converting enzyme 2 |
| ARDS | Acute respiratory distress syndrome |
| CDC | Centers for Disease Control and Prevention |
| CEACAM | Carcinoembryonic antigen-related cell adhesion molecule |
| GWAS | Genome-wide association study |
| HLA | Human leucocyte antigen |
| IL | Interleukin |
| ADAMTS13 | A disintegrin and metalloprotease (domain) of metallopeptidase with thrombospondin type 1 motif 13 |
| TLR | Toll-like receptor |
| Gal-9 | Galectin 9 |
| CRP | C-reactive protein |
| PRRs | Pattern recognition receptors |
| SNPs | single nucleotide polymorphism |
| cGAS-STING | cyclic GMP–AMP synthase (cGAS) stimulator of interferon gene (STING) |
| HIST1H2BO | Histone H2B type 1-O |
| HMGB1 | High mobility group box 1 gene |
| NLRP3 | NLR (nucleotide-binding domain and leucine-rich repeat containing) family pyrin domain containing 3 |
| TMPRSS2 | Transmembrane protease serine 2 |
| TCRA/D region | T cell receptor alpha/delta genes |
| TIMP1 | Metalloproteinase inhibitor 1 |
| IFNγ | Interferon gamma |
| IFIH | interferon induced with helicase C domain gene family |
| IRF | interferon regulatory factor gene family |
| PGE2 | Prostaglandin E2 |
| MMP | Matrix metalloproteinase |
| AP-1 | Activator protein 1 |
| J&J | Janssen Biotech Inc. and Johnson & Johnson |
| PBNT | Pfizer-BioNTech |
| VEGFA | Vascular endothelial growth factor A |
| GMCSF | Granulocyte–macrophage colony-stimulating factor |
| JAK 1/2 | Janus kinases |
| SIGLEC | Sialic acid–binding, immunoglobulin (Ig)-like lectin |
| TKI | Tyrosine kinase inhibitor |
| IL6Rα | Interleukin receptor alpha |
| IL1R | Interleukin 1 receptor |
| AP-1 | Activator protein-1 |
| MAPKs | Mitogen-associated protein kinase |
| ERKs | Extracellular signal-regulated kinase |